MARTINELLI, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 3.821
AS - Asia 3.553
EU - Europa 3.431
SA - Sud America 448
AF - Africa 79
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 11.342
Nazione #
US - Stati Uniti d'America 3.700
SG - Singapore 1.702
RU - Federazione Russa 1.095
IT - Italia 924
VN - Vietnam 698
CN - Cina 532
UA - Ucraina 431
BR - Brasile 357
HK - Hong Kong 334
DE - Germania 235
FR - Francia 173
NL - Olanda 128
FI - Finlandia 119
GB - Regno Unito 98
SE - Svezia 95
CA - Canada 72
IN - India 42
JP - Giappone 42
IE - Irlanda 37
AR - Argentina 34
MX - Messico 28
PL - Polonia 25
ZA - Sudafrica 25
BD - Bangladesh 23
IQ - Iraq 19
CI - Costa d'Avorio 18
PH - Filippine 18
TH - Thailandia 18
KR - Corea 17
AT - Austria 16
EC - Ecuador 16
TR - Turchia 16
ES - Italia 14
ID - Indonesia 14
PK - Pakistan 11
EG - Egitto 10
AE - Emirati Arabi Uniti 9
LT - Lituania 9
MA - Marocco 8
TW - Taiwan 8
VE - Venezuela 8
CO - Colombia 7
JO - Giordania 6
PY - Paraguay 6
UY - Uruguay 6
UZ - Uzbekistan 6
CL - Cile 5
IL - Israele 5
KZ - Kazakistan 5
NP - Nepal 5
PE - Perù 5
AM - Armenia 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
JM - Giamaica 4
AZ - Azerbaigian 3
BE - Belgio 3
BS - Bahamas 3
CH - Svizzera 3
HR - Croazia 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
AU - Australia 2
BB - Barbados 2
ET - Etiopia 2
IR - Iran 2
KE - Kenya 2
LV - Lettonia 2
ML - Mali 2
MN - Mongolia 2
NR - Nauru 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
AQ - Antartide 1
BG - Bulgaria 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
NA - Namibia 1
NE - Niger 1
Totale 11.327
Città #
San Jose 740
Singapore 724
Chandler 392
Hong Kong 318
Moscow 317
Jacksonville 315
Ashburn 217
Ho Chi Minh City 204
Hanoi 154
Beijing 151
Los Angeles 109
Millbury 108
The Dalles 102
Princeton 99
Santa Clara 98
Amsterdam 94
Lauterbourg 92
Napoli 74
Boston 70
Naples 63
Buffalo 57
Wilmington 53
Nanjing 47
Kronberg 40
Ottawa 37
Milan 35
Houston 34
Tokyo 33
New York 32
Council Bluffs 31
Munich 30
Da Nang 28
São Paulo 28
Hefei 27
Seattle 27
Orem 26
Palermo 25
Rome 25
Dallas 23
Nanchang 23
Frankfurt am Main 21
Denver 20
Helsinki 19
Haiphong 18
Norwalk 18
Dalmine 16
Des Moines 16
Orange 16
Warsaw 16
Hebei 15
Chennai 14
Montreal 14
Redondo Beach 14
Brooklyn 13
Changsha 13
Johannesburg 13
Mexico City 13
Poplar 13
Tianjin 13
Atlanta 12
Bari 12
Dong Ket 12
Hải Dương 12
Boardman 11
Chicago 11
Rio de Janeiro 11
Biên Hòa 10
Falkenstein 10
Luzzano 10
Manchester 10
Nuremberg 10
Shenyang 10
Verona 10
Vienna 10
Genoa 9
London 9
Stockholm 9
Bắc Giang 8
Pune 8
Toronto 8
Belo Horizonte 7
Bologna 7
Brasília 7
Bắc Ninh 7
Chieti 7
Guayaquil 7
Lawrence 7
Ninh Bình 7
Paris 7
Redwood City 7
Salvador 7
Thái Nguyên 7
Washington 7
Amman 6
Bangkok 6
Dhaka 6
Florence 6
Phoenix 6
Salerno 6
Seoul 6
Totale 5.742
Nome #
Leucemia acuta a cellule hand mirror con immunofenotipo ibrido: un caso clinico. 432
Deformazione di globuli rossi in flusso in microcapillari 234
Secondary syphilis mimicking malignancy: A case report and review of literature 212
Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation 179
Transition index: new original tool to identify subsets overlapping MPN phenotypes. 176
Clinical, Immunological, and Functional Characterization of Six Patients with Very High IgM Levels 175
A Novel Score to Predict Interferon-Alpha Therapy Responsiveness in Patients with Essential Thrombocythemia 168
EPIDEMIOLOGICAL, DIAGNOSTIC, THERAPEUTIC AND PROGNOSTIC ASPECTS OF ESSENTIAL THROMBOCYTHEMIA IN RETROSPECTIVE STUDY OF THE GIMMC GROUP IN TWO THOUSAND PATIENTS 157
La ciclosporina nella terapia della neutropenia "autoimmune" in una paziente con sindrome connettivitica. 156
HLA class I regulation of a T-cell leukemia proliferation 155
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma 153
CONTAGLOBULI AUTOMATICI E CORREZIONE DEL VALORE DI EMOGLOBINA IN PAZIENTI CON IPERLEUCOCITOSI 148
SPLEEN VOLUME IS THE MOST ACCURATE PARAMETER TO AVOID UNDERSTIMATION OF 25% SPLENOMEGALIC PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA 146
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 142
A methodology to study the deformability of red blood cells flowing in microcapillaries in vitro 139
UVB phototherapy for pruritus in polycythaemia vera 139
SPLEEN VOLUME ASSESSMENT IN HEMATOLOGIC DISEASES: CT VERSUS US 137
Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia. 137
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis 136
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 135
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib 134
L'uso delle sonde molecolari nella diagnostica delle malattie linfoproliferative e della leucemia mieloide cronica DNA probes for lymphoproliferative disorders and Chronic Myeloid Leukemia 132
Lenalidomide at the dose of 25 mg every other day in patients affected by multiple myeloma and renal failure: A real-life experience 131
Incidence of thyroiditis in Essential Thrombocythemia patients treated by a-IFN 126
Anagrelide in Essential Thrombocythemia: a retrospettive study” 125
JAK2 MUTATION IN PHILADELPHIA NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS: PRELIMINARY DATA FROM A SINGLE CENTRE 125
Deformability of red blood cells in microchannels 122
Randomized comparison of power Doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma. 119
Spectroscopical and Mechanical Characterization of Normal and Thalassemic Red Blood Cells by Raman Tweezers 119
11 CASI DI PSEUDOTROMBOCITOPENIA 118
Spleen sizing in essential thrombocythemia 115
Peg-Interferon a-2b in Essential Thrombocythaemia: phase II study for determination of the minimum effective, safe and tolerated dose, preliminary data 114
Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis 114
SAVING MONEY AND COMFORT BY GAINING CYTOSINE ARABINOSIDE MICROGRAMS 113
Randomized comparison of power Doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma. 110
Optical coherence tomography angiography features in Waldenström macroglobulinemia patients without Hyperviscosity syndrome: A pilot prospective study 107
80 CASI DI PSEUDOTROMBOCITOPENIA. 107
I geni Vk nella malattia di Waldestrom presentano mutazioni somatiche. 107
Splenectomy in idiopathic thrombocytopenic purpura: follow-up in 53 cases 107
LOCALIZATION OF THE BREAKPOINT IN THE M-BCR IN 31 CASES OF CML. PRELIMINARY OBSERVATIONS. 106
Residual disease detected by DNA analysis is predective of early relapse. 106
ADIA e linfoma 105
Localizzazione al nervo ottico in due casi di leucemia linfoblastica acuta con fenotipo T 105
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 105
Optic nerve involvement in acute lymphoblastic leukemia. 104
GATA-1: A potential novel biomarker for the differentiation of essential thrombocythemia and myelofibrosis 104
Severe Reactivation of Hepatitis B Virus Infection in a Patient with Hairy Cell Leukemia: Should Lamivudine Prophylaxis be Recommended to HBsAg-Negative, Anti-HBc-Positive Patients? 103
Randomized comparison of power Doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma 102
Caratterizzazione molecolare delle leucemie 102
LOW DOSE PEG INTERFERON A2B (PEG INTRON) IN ESSENTIAL THROMBOCYTHAEMIA 102
Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: Identification of a novel cluster 100
Interferon alfa treatment for pregnant women affected by essential thrombocythemia: case reports and a review. 100
Hypercitosis and spleen volume 99
SPLEEN ENLARGMENT FOLLOWING RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ADMINISTRATION FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION 97
L'entità dell'emolisi acida nella EPN in relazione alla forza ionica del mezzo 96
Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia. 96
Caratteristiche molecolari inusuali in un caso di leucemia acuta linfoblastica 95
Interferon to treat Essenzial Thrombocythemia during pregnancy: 4 cases and a letterature review 95
Lymphnode localization of extramedullary myeloid cell tumor in myelodysplastic syndrome: report of one case diagnosed by fine-needle cytology. 94
Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilization 93
High number of circulating CD34+ cells in patients with myelophthisis 92
L'analisi molecolare del DNA nelle leucemie con metodica non radioattiva 91
Complete phenotipic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia 91
Peg Interferon a- 2b (Peg Intron) in essential Thrombocythemia 89
Low dose of G- CSF and Cy-A in a case of severe neutropenia associated with clonal T-cell population 89
FATTORI AMBIENTALI E MALATTIE EMATOLOGICHE 88
A new pyrimidine 5’ nucleotidase variant? 88
Red blood cell deformability in microconfined shear flow 88
Differential Regulatory Role of Monomorphic and Polymorphic Determinants of Histocompatibility Leukocyte Antigen Class-i Antigens In Monoclonal-antibody Okt3-induced T-cell Proliferation 88
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™—the FUTURE study 88
Three good reasons for using Interferon in essential thrombocythemia: off-therapy achievement, complete remission maintained by low doses and unmodified bone marrow fibrosis 87
Long survival in two cases of acute myelogenous leukemia complicated by chronic active hepatitis 85
LONG SURVIVAL IN TWO CASES OF LEUKEMIA COMPLICATED BY CHRONIC ACTIVE HEPATITIS 85
Thirteen case of pseudothrombocitopenia 85
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. 84
ATTIVITÀ IN VITRO DELL'ALPHA-INTERFERON E DEI PUVA SUI PROGENITORI ERITROIDI CIRCOLANTI DEI POLICITEMICI 82
Interleuchina 2 ed interleuchina 1 sono fattori di regolazione autocrina nelle leucemie acute linfoblastiche e nelle leucemie linfatiche croniche 81
LA TERAPIA CONVENZIONALE DELLE SINDROMI MIELODISPLASTICHE 81
Severe reactivation of hepatitis B virus infection in a patient with hairy cell leukemia: Should lamivudine prophylaxis be recommended to HBsAg-negative, anti-HBc-positive patients? 81
Measurement of spleen volume by ultrasound scanning in patient with thrombocytosis: a prospective study 80
Bone marrow biopsy and aspirate evaluation in 90 patients with Essential Thrombocythemia treated with PEG Interferon alpha-2b. Preliminary results 77
Proliferative Pathways In Cd1- Cd3+ Cd4+ Cd8+ T-prolymphocytic Leukemic-cells - Analysis With Monoclonal-antibodies and Cytokines 77
RUOLO DELLE CITOCHINE NELL' INFEZIONE DA HTLV III 75
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program 74
RAMIPRIL IN POST-RENAL TRANSPLANT ERYTHROCYTOSIS 74
Optic nerve involvement in acute lymphoblastic leukemia 74
INTERLEUCHINA I AGISCE COME FATTORE AUTOCRINO DI PROLIFERAZIONE DI CELLULE B UMANE 74
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. 73
High number of circulating CD34+ cells in patients with myelophthisis. 72
NEUTROPENIA ASSOCIATED WITH LARGE GRANULAR LYMPHOCYTE PROLIFERATION: STUDY OF THREE CASES 71
Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia. 71
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia 70
UVB phototherapy for pruritus in polycythemia vera. 68
Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation 68
Late appearance of t(8;14) with c-myc rearrangement and disappearance of JH rearrangement leading to aggressive progression in a case of low grade non Hodgkin’s lymphoma” 68
Long term survival in acute myelogenous leukemia complicated by chronic active hepatitis 65
Narrowband (TL-01) ultraviolet B phototherapy for pruritus in polycythaemia vera 65
Delezione interstiziale del 9q in un caso di AML 65
PEG INTRON IN ESSENTIAL THROMBOCYTHAEMIA: TWO YEARS TREATAMENT EVALUTATION 64
Ramipril in post-renal transplant erythrocytosis. 62
Totale 10.940
Categoria #
all - tutte 34.929
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.929


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021112 0 0 0 0 0 0 0 0 0 0 93 19
2021/2022614 27 16 12 10 5 17 20 18 55 47 146 241
2022/2023867 130 93 37 87 84 96 4 76 109 97 43 11
2023/2024513 23 76 57 34 32 38 24 85 2 11 90 41
2024/20252.661 174 137 22 44 83 123 297 152 260 322 840 207
2025/20264.942 565 325 486 440 813 176 815 271 604 377 70 0
Totale 11.469